Skip to main content
. 2021 Jan 12;8(2):ofab011. doi: 10.1093/ofid/ofab011

Table 2.

Reproductive Health Parameters Among Women With and Without HIV

Whole Group (n = 42) Women With HIV (n = 23) Women Without HIV (n = 19) P Value
Absence of menses within the past year, % 64.3 69.6 (16/23) 57.9 (11/19) .52
Undetectable AMH, % 80.0 77.3 (17/22) 83.3 (15/18) .71
Presence of hot flashes, % 45.2 56.5 (13/23) 31.6 (6/19) .13
Average number of days per week with hot flashes 2.8 (0.6–7.0) 7.0 (1.3–7.0) (n = 12) 0.8 (0.0–2.1) (n = 6) .01
Duration of hot flashes, y 5.0 (1.7–9.0) 5.0 (1.8–12.0) (n = 11) 5.0 (1.3–8.0) (n = 7) .86
Current hormone therapy use, % 0.0 0.0 (0/23) 0.0 (0/19)
Current nonhormonal therapy use for menopause symptoms, % 5.0 9.5 (2/21) 0.0 (0/19) .49

Reproductive health parameters such as the percentage of participants with no menstrual cycle within the past year and the percentage of participants with an undetectable AMH did not differ significantly between women with vs without HIV. Women with HIV had a significantly higher number of days per week with hot flashes. None of the women in the study were currently on hormonal therapy with estrogen and/or progesterone. Normally distributed variables are presented as mean ± SD; non–normally distributed data are presented as median (interquartile range). P values <.05 were considered statistically significant and are presented in boldface.

Abbreviation: AMH, anti-Müllerian hormone.